Differential expression patterns and clinical significance of estrogen receptor-α and β in papillary thyroid carcinoma
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Differential expression patterns and clinical significance of estrogen receptor-α and β in papillary thyroid carcinoma
Authors
Keywords
ERα, ERβ1, Papillary thyroid cancer, Ki-67, Mutant P53, VEGF
Journal
BMC CANCER
Volume 14, Issue 1, Pages -
Publisher
Springer Nature
Online
2014-05-30
DOI
10.1186/1471-2407-14-383
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Co-regulatory potential of vascular endothelial growth factor–A and vascular endothelial growth factor–C in thyroid carcinoma
- (2013) Ali Salajegheh et al. HUMAN PATHOLOGY
- Relationship between Protein Expression of VEGF-C, MMP-2 and Lymph Node Metastasis in Papillary Thyroid Cancer
- (2013) X Tian et al. JOURNAL OF INTERNATIONAL MEDICAL RESEARCH
- The Ki-67/MIB-1 index level and recurrence of papillary thyroid carcinoma
- (2013) Nastaran Ranjbari et al. MEDICAL HYPOTHESES
- Differential expression patterns of estrogen receptor (ER)-β splice variants between papillary thyroid cancer and nodular thyroid goiter
- (2013) Wenwu Dong et al. MEDICAL SCIENCE MONITOR
- Activation of estrogen receptor β reduces blood–brain barrier breakdown following ischemic injury
- (2013) J.A. Shin et al. NEUROSCIENCE
- Estrogen Induces Metastatic Potential of Papillary Thyroid Cancer Cells through Estrogen Receptorαandβ
- (2013) Wenwu Dong et al. International Journal of Endocrinology
- Developments in Ki67 and other biomarkers for treatment decision making in breast cancer
- (2012) A. Sheri et al. ANNALS OF ONCOLOGY
- Estrogen receptor signaling as a target for novel breast cancer therapeutics
- (2012) Jack-Michel Renoir et al. BIOCHEMICAL PHARMACOLOGY
- Expression of the proliferation marker Ki-67 associates with tumour staging and clinical outcome in differentiated thyroid carcinomas
- (2012) Karsten Müssig et al. CLINICAL ENDOCRINOLOGY
- Expression of estrogen and androgen receptors in differentiated thyroid cancer: an additional criterion to assess the patient's risk
- (2012) Flavia Magri et al. ENDOCRINE-RELATED CANCER
- Investigation of immunohistochemical ERα, ERβ and ERβcx expressions in normal and neoplastic breast tissues
- (2012) Kemal Kürşat Bozkurt et al. PATHOLOGY RESEARCH AND PRACTICE
- Loss of Estrogen Receptor Beta Expression in Follicular Thyroid Carcinoma Predicts Poor Outcome
- (2012) Annukka Heikkilä et al. THYROID
- Comparison of proliferating cell nuclear antigen, thyroid transcription factor-1, Ki-67, p63, p53 and high–molecular weight cytokeratin expressions in papillary thyroid carcinoma, follicular carcinoma, and follicular adenoma
- (2011) Ayca Tan et al. Annals of Diagnostic Pathology
- Estrogen-Mediated Angiogenesis in Thyroid Tumor Microenvironment Is Mediated Through VEGF Signaling Pathways
- (2011) Ameet Kamat ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY
- Estrogen activity as a preventive and therapeutic target in thyroid cancer
- (2011) Shilpi Rajoria et al. BIOMEDICINE & PHARMACOTHERAPY
- Overexpression of estrogen receptor-α in human papillary thyroid carcinomas studied by laser-capture microdissection and molecular biology
- (2011) Maura Di Vito et al. CANCER SCIENCE
- A High-Throughput Proteomic Approach Provides Distinct Signatures for Thyroid Cancer Behavior
- (2011) S. Cheng et al. CLINICAL CANCER RESEARCH
- Minireview: Putting Physiology Back into Estrogens' Mechanism of Action
- (2011) Robert D. Koos ENDOCRINOLOGY
- Correlation of E-cadherin, VEGF, COX-2 expression to prognostic parameters in papillary thyroid carcinoma
- (2011) Havva Erdem et al. EXPERIMENTAL AND MOLECULAR PATHOLOGY
- Prognostic value of oncoprotein expressions in thyroid papillary carcinoma
- (2011) A. Z. Balta et al. MEDICAL ONCOLOGY
- BRAF, p53 and SOX2 in anaplastic thyroid carcinoma: evidence for multistep carcinogenesis
- (2011) Guillaume Gauchotte et al. PATHOLOGY
- Selectively targeting estrogen receptors for cancer treatment
- (2010) Erin K. Shanle et al. ADVANCED DRUG DELIVERY REVIEWS
- The American Joint Committee on Cancer: the 7th Edition of the AJCC Cancer Staging Manual and the Future of TNM
- (2010) Stephen B. Edge et al. ANNALS OF SURGICAL ONCOLOGY
- Immunohistochemical characteristics of diffuse sclerosing variant of papillary carcinoma: comparison with conventional papillary carcinoma
- (2010) JA SEUNG KOO et al. APMIS
- Nuclear and cytoplasmic expressions of ERβ1 and ERβ2 are predictive of response to therapy and alters prognosis in familial breast cancers
- (2010) Max Yan et al. BREAST CANCER RESEARCH AND TREATMENT
- Understanding wild-type and mutant p53 activities in human cancer: new landmarks on the way to targeted therapies
- (2010) I Goldstein et al. CANCER GENE THERAPY
- Thyroid cancer gender disparity
- (2010) Reza Rahbari et al. Future Oncology
- Immunohistochemical evaluation of inflammatory and proliferative markers in adjacent normal thyroid tissue in patients undergoing total thyroidectomy: results of a preliminary study
- (2010) Guglielmo Ardito et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Estrogen receptor acting in cis enhances WT and mutant p53 transactivation at canonical and noncanonical p53 target sequences
- (2010) D. Menendez et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Papillary Thyroid Carcinoma With Prominent Hobnail Features: A New Aggressive Variant of Moderately Differentiated Papillary Carcinoma. A Clinicopathologic, Immunohistochemical, and Molecular Study of Eight Cases
- (2009) Sofia Asioli et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Controversies in Thyroid Pathology: Thyroid Capsule Invasion and Extrathyroidal Extension
- (2009) Ozgur Mete et al. ANNALS OF SURGICAL ONCOLOGY
- Expression of oestrogen receptors, ERα, ERβ, and ERβ variants, in endometrial cancers and evidence that prostaglandin F may play a role in regulating expression of ERα
- (2009) Frances Collins et al. BMC CANCER
- Gender is an Age-Specific Effect Modifier for Papillary Cancers of the Thyroid Gland
- (2009) B. A. Kilfoy et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Clinical and molecular features of differentiated thyroid cancer diagnosed during pregnancy
- (2009) Guia Vannucchi et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Regulation of Cell Growth by Estrogen Signaling and Potential Targets in Thyroid Cancer
- (2008) George Chen et al. CURRENT CANCER DRUG TARGETS
- Clinical Significance of P53 Protein Expression in Papillary Thyroid Carcinoma
- (2008) Naomi Morita et al. WORLD JOURNAL OF SURGERY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started